AI Stock Analysis - Kala Pharmaceuticals (KALA)
Analysis generated December 4, 2025.
Kala Pharmaceuticals is a biopharmaceutical company that focuses on the development and commercialization of innovative therapies for eye diseases. The company aims to address significant unmet medical needs in ophthalmology through its proprietary nanoparticle-based technology.
Stock Alerts - Kala Pharmaceuticals (KALA)
 |
Kala Pharmaceuticals | February 17 Price is up by 7.9% in the last 24h. |
|
Kala Pharmaceuticals | February 13 Price is up by 7.4% in the last 24h. |
|
Kala Pharmaceuticals | February 12 Price is down by -6% in the last 24h. |
|
Kala Pharmaceuticals | February 11 Price is down by -7.2% in the last 24h. |
Download our app to get future alerts delivered in real-time.
Alternative Data for Kala Pharmaceuticals
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 8,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 29 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 9,714 | Sign up | Sign up | Sign up |
| X Mentions | 22 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
About Kala Pharmaceuticals
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development and commercialization of therapies using its proprietary nanoparticle-based mucus penetrating particle (MPP) technology for the treatment of eye diseases. The company is headquartered in Watertown, Massachusetts.
| Price | $0.41 |
| Target Price | Sign up |
| Volume | 545,540 |
| Market Cap | $370M |
| Year Range | $0.36 - $19.63 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 0 | 0 | 0 | -7.6M | -6.5M | -1.070 |
| Q2 '25 | 0 | 67,000 | -67,000 | -11M | -10M | -1.710 |
| Q1 '25 | 0 | 0 | -68,000 | -8.9M | -7.8M | -1.741 |
| Q4 '24 | 250,000 | 69,000 | 130,000 | -8.2M | -6.7M | -1.232 |
| Q3 '24 | 0 | 63,000 | -63,000 | -9M | -7.4M | -1.934 |
Insider Transactions View All
| Reumuth Mary filed to sell 28,906 shares at $0.8. October 24 '25 |
| Iwicki Mark T filed to sell 103,540 shares at $0.8. October 24 '25 |
| Brazzell Romulus K filed to sell 35,952 shares at $0.8. October 24 '25 |
| Bazemore Todd filed to sell 35,932 shares at $0.8. October 24 '25 |
| Reumuth Mary filed to sell 29,873 shares at $0.8. October 24 '25 |
Similar companies
Read more about Kala Pharmaceuticals (KALA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, x mentions, news mentions & customer reviews.
FAQ - Kala Pharmaceuticals
The Market Cap of Kala Pharmaceuticals is $370M.
Currently, the price of one share of Kala Pharmaceuticals stock is $0.41.
The KALA stock price chart above provides a comprehensive visual representation of Kala Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Kala Pharmaceuticals shares. Our platform offers an up-to-date KALA stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Kala Pharmaceuticals (KALA) does not offer dividends to its shareholders. Investors interested in Kala Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Kala Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
